Scientists probe Body's hidden defense against dengue

NCT ID NCT07158190

Summary

This study aims to understand how the body's T-cells respond to a new dengue vaccine called TAK-003. Researchers will enroll 30 healthy adults to analyze their immune system's reaction after vaccination. The goal is to identify markers that show if the body is protected against the dengue virus, which could help improve future vaccines.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENGUE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fondazione Policlinico Universtiario Agostino Gemelli IRCCS

    Rome, Roma, 00168, Italy

Conditions

Explore the condition pages connected to this study.